Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

Buprenorphine treatment for opioid use disorder: recent progress.

Parida S, Carroll KM, Petrakis IL, Sofuoglu M.

Expert Rev Clin Pharmacol. 2019 Jun 30:1-13. doi: 10.1080/17512433.2019.1635454. [Epub ahead of print]

PMID:
31232604
2.

Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect-Reply.

Krystal JH, Yoon G, Petrakis IL.

JAMA Psychiatry. 2019 May 1. doi: 10.1001/jamapsychiatry.2019.0763. [Epub ahead of print] No abstract available.

PMID:
31042270
3.

Sex differences in stress-related alcohol use.

Peltier MR, Verplaetse TL, Mineur YS, Petrakis IL, Cosgrove KP, Picciotto MR, McKee SA.

Neurobiol Stress. 2019 Feb 8;10:100149. doi: 10.1016/j.ynstr.2019.100149. eCollection 2019 Feb. Review.

4.

Targeting neuroinflammation with minocycline in heavy drinkers.

Petrakis IL, Ralevski E, Gueorguieva R, Sloan ME, Devine L, Yoon G, Arias AJ, Sofuoglu M.

Psychopharmacology (Berl). 2019 Mar 27. doi: 10.1007/s00213-019-05205-3. [Epub ahead of print]

PMID:
30919006
5.

Alcohol Abstainer Status and Prazosin Treatment in Association with Changes in Posttraumatic Stress Disorder Symptoms in Veterans with Comorbid Alcohol Use Disorder and Posttraumatic Stress Disorder.

Verplaetse TL, Ralevski E, Roberts W, Gueorguieva R, McKee SA, Petrakis IL.

Alcohol Clin Exp Res. 2019 Apr;43(4):741-746. doi: 10.1111/acer.13969. Epub 2019 Feb 19.

PMID:
30698839
6.

Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder.

Yoon G, Petrakis IL, Krystal JH.

JAMA Psychiatry. 2019 Jan 9. doi: 10.1001/jamapsychiatry.2018.3990. [Epub ahead of print] No abstract available.

PMID:
30624551
7.

What Role Should Psychiatrists Have in Responding to the Opioid Epidemic?

Muvvala SB, Edens EL, Petrakis IL.

JAMA Psychiatry. 2019 Feb 1;76(2):107-108. doi: 10.1001/jamapsychiatry.2018.3123. No abstract available.

PMID:
30484813
8.

Tobacco use during a clinical trial of mecamylamine for alcohol dependence: Medication effects on smoking and associations with reductions in drinking.

Roberts W, Ralevski E, Verplaetse TL, McKee SA, Petrakis IL.

J Subst Abuse Treat. 2018 Nov;94:91-96. doi: 10.1016/j.jsat.2018.08.015. Epub 2018 Sep 2.

PMID:
30243424
9.

Trauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder.

Meshberg-Cohen S, Black AC, DeViva JC, Petrakis IL, Rosen MI.

Addict Behav. 2019 Feb;89:29-34. doi: 10.1016/j.addbeh.2018.09.010. Epub 2018 Sep 12.

PMID:
30243036
10.

Is Pretreatment Blood Pressure a Marker of Prazosin Response in Posttraumatic Stress Disorder With Comorbid Alcohol Use Disorder?

Manhapra A, Ralevski E, Petrakis IL.

Biol Psychiatry. 2019 Feb 1;85(3):e11-e12. doi: 10.1016/j.biopsych.2018.07.011. Epub 2018 Aug 24. No abstract available.

PMID:
30143236
11.

Suicidal ideation in military veterans with alcohol dependence and PTSD: The role of hostility.

Kachadourian LK, Gandelman E, Ralevski E, Petrakis IL.

Am J Addict. 2018 Mar;27(2):124-130. doi: 10.1111/ajad.12688.

PMID:
29489046
12.

Naltrexone and Disulfiram Treatment Response in Veterans With Alcohol Dependence and Co-Occurring Problem-Gambling Features.

Grant JE, Potenza MN, Kraus SW, Petrakis IL.

J Clin Psychiatry. 2017 Nov/Dec;78(9):e1299-e1306. doi: 10.4088/JCP.16m11220.

PMID:
29345864
14.

GRIK1 and GABRA2 Variants Have Distinct Effects on the Dose-Related Subjective Response to Intravenous Alcohol in Healthy Social Drinkers.

Yang BZ, Arias AJ, Feinn R, Krystal JH, Gelernter J, Petrakis IL.

Alcohol Clin Exp Res. 2017 Dec;41(12):2025-2032. doi: 10.1111/acer.13516. Epub 2017 Nov 13.

15.

The Importance of Identifying Characteristics Underlying the Vulnerability to Develop Alcohol Use Disorder.

Petrakis IL.

Am J Psychiatry. 2017 Nov 1;174(11):1034-1035. doi: 10.1176/appi.ajp.2017.17080915. No abstract available.

PMID:
29088935
16.

Rapid Identification of Buprenorphine in Patient Saliva.

Farquharson S, Dana K, Shende C, Gladding Z, Newcomb J, Dascher J, Petrakis IL, Arias AJ.

J Anal Bioanal Tech. 2017 Jun;8(3). pii: 368. doi: 10.4172/2155-9872.1000368. Epub 2017 Jun 23.

17.

Partnering with Psychiatry to Close the Education Gap: An Approach to the Addiction Epidemic.

Tetrault JM, Petrakis IL.

J Gen Intern Med. 2017 Dec;32(12):1387-1389. doi: 10.1007/s11606-017-4140-9. Epub 2017 Aug 1.

18.

Mecamylamine treatment for alcohol dependence: a randomized controlled trial.

Petrakis IL, Ralevski E, Gueorguieva R, O'Malley SS, Arias A, Sevarino KA, Jane JS, O'Brien E, Krystal JH.

Addiction. 2018 Jan;113(1):6-14. doi: 10.1111/add.13943. Epub 2017 Oct 12.

19.

NMDA Glutamate Receptor Antagonism and the Heritable Risk for Alcoholism: New Insights from a Study of Nitrous Oxide.

Krystal JH, Petrakis IL, O'Malley S, Krishnan-Sarin S, Pearlson G, Yoon G.

Int J Neuropsychopharmacol. 2017 Apr 1;20(4):351-353. doi: 10.1093/ijnp/pyw118. No abstract available.

20.

Posttraumatic Stress Disorder and Alcohol Use Disorder: A Critical Review of Pharmacologic Treatments.

Petrakis IL, Simpson TL.

Alcohol Clin Exp Res. 2017 Feb;41(2):226-237. doi: 10.1111/acer.13297. Epub 2017 Jan 19. Review.

Supplemental Content

Loading ...
Support Center